Tech Company Financing Transactions
BiOptix Funding Round
On 3/24/2010, BiOptix landed $9 million in Series B funding from Boulder Ventures and private investors.
Transaction Overview
Company Name
Announced On
3/24/2010
Transaction Type
Venture Equity
Amount
$9,000,000
Round
Series B
Investors
Boulder Ventures (Kyle Lefkoff)
Proceeds Purpose
This investment allows us to tap into new markets and resources that were unavailable to us in thepast.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
1775 38th St.
Boulder, CO 80301
USA
Boulder, CO 80301
USA
Phone
Website
Email Address
Overview
BiOptix offers an affordable and powerful solution for drug discovery scientists that require label-free, real-time detection of biomolecular interactions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Whitcomb
VP - Engineering
Kevin Ryan
VP - Marketing
Ken Wilczek
VP - R & D
Slava Petropavlovskikh
VP - Sales
Ken Dickerson
Browse more venture capital transactions:
Prev: 3/23/2010: Aerohive Networks venture capital transaction
Next: 3/24/2010: Avatar Reality venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs